Plasma sphingomyelin and longitudinal change in percent emphysema on CT. The MESA Lung study

Biomarkers

Volumn 19, Issue 3, 2014, Pages 207-213

  Ahmed, Firas S ^a   Jiang, Xian Cheng ^b   Schwartz, Joseph E ^a   Hoffman, Eric A ^c   Yeboah, Joseph ^d   Shea, Steven ^a,e   Burkart, Kristin Marie ^a   Barr, R Graham ^a,e  

^a Department of Medicine College of Physicians and Surgeons Columbia University ^*  (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e Department of Medicine   (United States)

Author keywords

Ceramide; Computed tomography; Emphysema; Sphingomyelin

Indexed keywords

SPHINGOMYELIN;

ADULT; ARTICLE; CARDIAC IMAGING; COHORT ANALYSIS; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; LIPID BLOOD LEVEL; LONGITUDINAL STUDY; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; MALE; NORMAL VALUE; PREDICTIVE VALUE; PROSPECTIVE STUDY; QUANTITATIVE DIAGNOSIS; SINGLE BLIND PROCEDURE; AGED; BLOOD; EMPHYSEMA; MIDDLE AGED; PATHOPHYSIOLOGY; RADIOGRAPHY;

AGED; EMPHYSEMA; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; SPHINGOMYELINS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84899758399     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2014.896414     Document Type: Article

References (40)

1. Auerbach O, Hammond E, Garfinkel L, et al. (1972). Relation of smoking and age to emphysema-whole-lung section study. N Engl J Med 286:853-957.
2. Bartlett G. (1959). Phosphorus assay in column chromatography. J Biol Chem 234:466-8.
3. Bild D, Bluemke D, Burke G, et al. (2002). Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 156:871-81.
4. Bligh E, Dyer W. (1959). A rapid method for total lipid extraction and purification. Can J Biochem Physiol 37:911-17.
5. Carr JJ Nelson JC Wong ND et al. 2005, Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) Study, Radiology , 234,35-43.
6. Celli B, Macnee W, Agusti A, et al. (2004). Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper. Eur Respir J 23:932-46.
7. Coxson HO, Mayo JR, Behzad H, et al. (1995). Measurement of lung expansion with computed tomography and comparison with quantitative histology. J Appl Physiol 79:1525-30.
8. Devlin CM, Leventhal AR, Kuriakose G,et al. (2008). Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progression. Atheroscler Thromb Vasc Biol 28:1723-30.
9. Filippov V, Song MA, Zhang K, et al. (2012). Increased ceramide in brains with Alzheimer?s and other neurodegenerative diseases. J Alzheimer?s Dis 29:537-47.
10. Filosto S, Castillo S, Danielson A, et al. (2011). Neutral sphingomyelinase 2: A novel target in cigarette smoke-induced apoptosis and lung injury. Am J Respir Cell Mol Biol 44:350-60.
11. Guillemot N, Troadec C, Villemeur TBD, et al. (2007). Lung disease in Niemann-Pick disease. Pediatr Pulmonol 42:1207-14.
12. Hankinson J, Kawut S, Shahar E, et al. (2010). Performance of American Thoracic Society-recommended spirometry reference values in a multiethnic sample of adults: the Multi-Ethnic Study of Atherosclerosis (MESA) lung study. Chest 137:138-45.
13. Hankinson J, Odencrantz J, Fedan K. (1999). Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 159:179-87.
14. Hannun Y, Obeid L. (2002). The ceramide-centric universe of lipidmediated cell regulation: stress encounters of the lipid kind. J Biol Chem 277:25847-50.
15. Hannun YA, Obeid LM. (2008). Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9:139-50.
16. Haruna A, Muro S, Nakano Y, et al. (2010). CT scan findings of emphysema predict mortality in COPD. Chest 138:635-40.
17. Hoffman EA, Jiang R, Baumhauer H, et al. (2009). Reproducibility and validity of lung density measures from cardiac CT scans-the Multi-Ethnic Study of Atherosclerosis (MESA) lung study. Acad Radiol 16:689-99.
18. Hojjati M, Jiang X. (2006). Rapid, specific, and sensitive measurements of plasma sphingomyelin and phosphatidylcholine. J Lipid Res 47: 673-6
19. Jiang XC, Paultre F, Pearson TA, et al. (2000). Plasma sphingomyelin level as a risk factor for coronary artery disease. Atheroscler Thromb Vasc Biol 20:2614-18.
20. Lederer D, Enright P, Kawut S, et al. (2009). Cigarette smoking is associated with subclinical parenchymal lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA)-lung study. Am J Respir Crit Care Med 180:407-14.
21. Levade T, Andrieu-Abadie N, SéGui BA, et al. (1999). Sphingomyelindegrading pathways in human cells: role in cell signalling. Chem Phys Lipids 102:167-78.
22. Marathe S, Schisse S, Yellin M, et al. (1998). Human vascular endothelial cells are a rich and regulatable source of secretory sphingomyelinase. J Biol Chem 273:4081-8.
23. Medler TR, Petrusca DN, Lee PJ, et al. (2008). Apoptotic sphingolipid signaling by ceramides in lung endothelial cells. Am J Respir Cell Mol Biol 38:639-46.
24. MESA Manual of Operations. Field Center and Laboratory Procedures [Online]. Seattle: University of Washington. Available at: http://www.mesa- nhlbi.org/manuals.aspx [last accessed 23 Dec 2009].
25. Miller MR, Hankinson J, Brusasco V, et al. (2005). Standardisation of spirometry. Eur Respir J 26:319-38.
26. Pauwels R, Buist A, Calverley P, et al. (2001). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med 163:1256-76.
27. Pellegrino R, Viegi G, Brusasco V, et al. (2005). Interpretative strategies for lung function tests. Eur Respir J 26:948-68.
28. Petrache I, Natarajan V, Zhen L, et al. (2005). Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat Med 11:491-8.
29. Petrache I, Petrusca DN. (2013). The involvement of sphingolipids in chronic obstructive pulmonary diseases. In: Gulbins E, Petrache I, eds. Handbook of experimental pharmacology. Wien: Springer-Verlag, 492-6.
30. Petrache I, Petrusca DN, Bowler RP, et al. (2011). Involvement of ceramide in cell death responses in the pulmonary circulation. Proc Am Thorac Soc 8:492-6.
31. Psaty BM, Lee M, Savage PJ, et al. (1992). Assessing the use of medications in the elderly: methods and initial experience in the cardiovascular health study. J Clin Epidemiol 45:683-92.
32. Reddy J, Mccauley K, Goya J, et al. (2011). Correlations of lung ceramide expression with clinical parameters in COPD. American Thoracic Soceity Annual Meeting. Denver, Colorado: American Jouranl of Respiratory and Critical Care Medicine.
33. Reddy SB, Barr BK. (2005). Quantitative evaluation of emphysema presence and distribution via coronary calcium CT compared with full lung study. Abstract presented at: The International Conference of the Radiological Society of North America November 27-December 2, 2005 Chicago, IL.
34. Reunanen N, Westermarck J, Häkkinen L, et al. (1998). Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways. J Biol Chem 273: 5137-45.
35. Rodriguez J, Jiang R, Johnson WC, et al. (2010). The association of pipe and cigar use with cotinine levels, lung function and airflow obstruction: A cross-sectional study. Ann Intern Med 152:201-10.
36. Soriano J, Davis K, Coleman B, et al. (2003). The proportional Venn diagram of obstructive lung disease. Chest 124:474-81.
37. Tuder RM, Yoshida T, Fijalkowka I, et al. (2006). Role of lung maintenance program in the heterogeneity of lung destruction in emphysema. Proc Am Thorac Soc 3:673-9.
38. van Belle G, Fisher L, Heagerty PJ, et al. (2004). Chapter 18: longitudinal data analysis. Biostatistics: A methodology for the health sciences. Hoboken (NJ): John Wiley & Sons.
39. Zhang L, Hoffman EA, Reinhardt J. (2006). Atlas-driven lung lobe segmentation in volumetric X-ray CT images. IEEE Trans Med Imaging 25:1-16.
40. Zulueta J, Wisnivesky J, Henschke C, et al. (2012). Emphysema scores predict death from COPD and lung cancer. Chest 141:1216-23.